Abstract
Background
While recognizing the etiology of community-acquired pneumonia is necessary for formulating local antimicrobial guidelines, limited data is published about this etiology in Egyptian pediatric patients.
Objectives
To determine the frequency of bacterial and viral pathogens causing community-acquired pneumonia (CAP) among immunocompetent Egyptian infants and preschool children.
Methods
Ninety infants and preschool-age children admitted to our hospital with CAP were prospectively included in the study. Etiological agents were identified using conventional bacteriological identification methods and IgM antibodies detection against common atypical respiratory bacteria and viruses.
Results
An etiology was identified in 59 patients (65.5%). Bacterial pathogens were detected in 43 (47.8%) of the cases while viral pathogens were detected in 23 (25.5%). Coinfection with more than one etiologic agent was evident in seven patients (7.8%). The most common typical bacterial cause of pneumonia was Staphylococcus aureus (n = 12, 13.3%), followed by Streptococcus pneumoniae and Klebsiella pneumoniae (n = 7, 7.8%, each). The commonest atypical bacterium was Mycoplasma pneumoniae (n = 10, 11.1%), whereas the commonest viral etiology was influenza viruses (n = 11, 12.2%).
Conclusion
Although we could not determine the causative agent in some studied cases, this study provides preliminary data regarding the spectrum and frequency of microorganisms causing CAP in Egyptian infants and preschool children.
Keywords: pneumonia, respiratory infection, bacterial, viral, developing countries
Background
Respiratory infections have always been considered a worldwide health problem and a major cause of morbidity and mortality, with infants and young children especially susceptible [1]. Among these infections, pneumonia stays the predominant cause of childhood mortality, causing nearly 1.2 million deaths each year in children younger than 5 years. Most of these deaths occur in developing countries [2]. In Egypt, it was estimated that 10% of children deaths below the age of 5 years is likely caused by pneumonia and other acute respiratory infections [3]. Community-acquired pneumonia (CAP) is one of the most common serious infections in children. Its incidence among children aged less than 5 years in developing countries reached 0.29 #child per year, with a mortality rate of 1.3–2.6% [4]. Pediatric CAP is defined as the presence of signs and symptoms of pneumonia in a previously healthy child due to an infection which has been acquired outside hospital [5]. Determining the etiology of CAP is still difficult in routine clinical settings considering the difficulty in obtaining appropriate lower respiratory tract specimens from children. A considerable seasonal and geographical difference in such etiology has been reported. In most studies, Streptococcus pneumoniae has been the most common etiologic agent identified [6]. Available therapeutic guidelines for the empirical treatment of CAP rely on studies from the Western world. There is little information about the prevalence of microorganisms causing CAP in Egypt.
Aim of the work
This study aimed to elucidate the common bacterial and viral pathogens causing CAP among immunocompetent Egyptian infants and preschool children admitted to the pediatric hospital of Ain Shams University and clarify the associated clinical characteristics in order to contribute to establishment of local guidelines for empirical antimicrobial therapy.
Materials and methods
Study design and patient selection
This prospective descriptive study was conducted on children, aged 1–72 months old, consecutively admitted to the children’s unit of Ain Shams university hospitals from February 2012 to March 2013 with CAP. Children were eligible if they presented with clinical signs of pneumonia according to the World Health Organization criteria [7].
Exclusion criteria included children aged less than 1 month and those with an underlying chronic disease, immunosuppressed status, history of recurrent attacks of pneumonia, antibiotic intake within the last month, intake of pneumococcal vaccine, healthcare associated and hospital acquired pneumonia.
Data collection
Data was collected from each patient using a standardized data collection form. Recorded data included demographic characteristics, the date of the beginning of the current respiratory symptoms, antimicrobial intake, vaccination status, comorbidities, and presenting symptoms and signs.
Radiology
Chest x-ray was performed and interpreted according to Cherian et al. [8].
Routine laboratory investigations
On admission, a blood sample was taken for assessment of total white blood cell count with manually verified differential count, hemoglobin, platelet count, and qualitative assessment of serum C-reactive protein (CRP).
Microbiologic workup
Specimens for bacteriologic culture were collected before starting antimicrobial therapy.
Respiratory specimens
Respiratory specimens were collected either by sputum induction or cough swab technique. Induced sputum samples were taken as previously described by Zar et al. [9]. Patients were pretreated with inhaled salbutamol delivered by a nebulizer device and then hypertonic saline 5.0% for 10 min. Sputum samples were then obtained by aspirating the nasopharynx through the nostrils with a disposable mucus extractor or by expectoration if the child was old enough to produce an adequate sputum sample. Cough swab was done by nebulization with normal saline first, and then, gag reflex was stimulated by irritation of uvula to initiate cough in the same time a sterile swab was put in front of the mouth droplets without touching the posterior pharynx [10].
Blood for blood culture and serology
Appropriate amount (according to the age) of venous blood was collected aseptically by venipuncture. Two milliliters of the sample was retained for serum separation, and the rest was evacuated into the blood culture bottle (Vacsera, Cairo, Egypt).
All samples were transferred immediately after collection to the Infectious Diseases Research and Infection Control Unit at Medical Microbiology and Immunology Department of Ain Shams University for further processing.
Processing of specimens
Respiratory specimens were subjected to the following:
Inoculation on blood agar, heated blood agar, and MacConkey’s agar media;
Direct smear staining with Gram stain for microscopic examination.
All sputum cultures were screened for interpretability; only those with >25 leukocytes and <10 epithelial cells per low power field were selected [11]. Inoculated blood and MacConkey’s agar plates were incubated at 37 °C aerobically while inoculated heated blood agar plates were incubated at CO2 10% by the candle jar method. Blood cultures were incubated overnight at 37 °C. A blind subculture was done on blood agar plates after overnight incubation; if no growth was obtained, the bottles were examined daily for 7 days. Any sign of growth was followed by subculture. Isolates obtained from respiratory and blood cultures were completely identified using standard techniques [12].
Serological diagnosis
The clotted blood samples were centrifuged at 1000 g for 10 min. Sera were separated and stored at –20 °C until assayed by indirect immunofluorescent technique for the presence of specific IgM antibodies against common respiratory pathogens, namely, Legionella pneumophila serogroup 1, Mycoplasma pneumoniae, Coxiella burnetii, Chlamydophila pneumoniae, adenovirus, respiratory syncytial virus (RSV), influenza A, influenza B, and parainfluenza viruses serotypes 1, 2, and 3, using Pneumoslide-M test (Vircell, Granada, Spain). Serum samples were diluted 1:1 with phosphate buffered saline (PBS) and then treated with antihuman IgG sorbent. The sorbent-treated diluted serum was incubated for 90 min at 37 °C with the ten slide wells. The slide was washed twice with PBS. A fluorescent secondary IgM antibody was added to the wells and incubated at 37 °C for 30 min, and then washed twice with PBS. Positive and negative controls were included in each test run. The slide was read using Zeiss fluorescence microscope at 400× magnification [13].
Statistical analysis
Continuous variables are expressed as mean and standard deviation (SD). Categorical variables are expressed as frequencies and percent. Chi-square and Fisher’s exact tests were used to examine the relationship between categorical variables. Student t-test was used to assess the statistical significance of the difference between two study group mean. A significance level of p < 0.05 was used in all tests. All statistical procedures were carried out using SPSS version 15 for Windows (SPSS Inc., Chicago, IL, USA).
Ethics statement
Informed consents were obtained from informed parents or guardians. The work has been approved by ASU Ethics Committee and was carried out in accordance with the ethical guidelines of the Declaration of Helsinki, 1975.
Results
Ninety infants and preschool children with CAP were included in the study. The mean age of the studied population was 21.30 ± 16.93 months (range 1–72 months), 60 (66.7%) were below 2 years and 30 (33.3%) ranged between 2 years and 5.5 years old. Fifty-seven (63.3%) were male, and 65 (72.2%) came from rural areas. The demographic and clinical characteristics of all cases are summarized in Table 1.
Table 1.
Characteristics | Total number (%) | Typical bacterial | Atypical bacterial | Viral | Mixed | Unidentified pathogen |
---|---|---|---|---|---|---|
Patients | 90 (100%) | 26 (28.9%) | 9 (10%) | 17 (18.9%) | 7 (7.8%) | 31 (34.4%) |
Demographic characteristics | ||||||
Age in months (mean ± SD) | 21.30 ± 16.93 | 21.4 ± 16.56 | 24.88 ± 14.58 | 20.71 ± 14.15 | 15.85 ± 15.2 | 22.5 ± 20.05 |
Age group | ||||||
≤2 years | 60 (66.7%) | 17 | 5 | 11 | 6 | 21 |
>2 years | 30 (33.3) | 9 | 4 | 6 | 1 | 10 |
Sex | ||||||
Female | 33 (36.7%) | 9 | 6 | 7 | 4 | 7 |
Male | 57 (63.3%) | 17 | 3 | 10 | 3 | 24 |
Residence | ||||||
Urban | 25 (27.8%) | 8 | 4 | 5 | 4 | 4 |
Rural | 65 (72.2%) | 18 | 5 | 12 | 3 | 27* |
Clinical findings | ||||||
Fever | 83 (92.2) | 24 | 9 | 15 | 7 | 29 |
Rhinitis | 86 (95.6) | 24 | 9 | 17 | 7 | 31 |
Cough | 67 (74.4) | 21 | 6 | 10 | 6 | 24 |
Grunting | 42 (46.7%) | 12 | 10 | 5 | 9 | 6 |
Cyanosis | 22 (24.4%) | 6 | 6 | 2 | 6 | 2 |
Diminished air entry | 84 (93.3%) | 30 | 24 | 9 | 15 | 7 |
Fine crepitation | 89 (98.9%) | 26 | 9 | 17 | 7 | 30 |
Rhonchi | 55 (61.1%) | 20 | 15 | 5 | 10 | 5 |
Wheezes | 44 (48.9) | 12 | 5 | 7 | 4 | 16 |
Rapid breathing | 90(100) | 26 | 10 | 18 | 5 | 31 |
R.R. (mean ± SD) | 55.78 ± 7.08 | 55.62 ± 6.00 | 54.40 ± 6.50 | 52.78 ± 5.49* | 59.0 ± 4.18 | 57.58 ± 8.69 |
Severe respiratory distress | 24 (26.7) | 4 | 6 | 2 | 6* | 6* |
Laboratory findings | ||||||
Leukocytosis | 41 (45.6%) | 10 | 5 | 10 | 5 | 11 |
Neutrophilia | 26 (28.9%) | 6 | 4 | 9* | 5* | 2 |
Neutropenia | 0 (0.0%) | 0 | 0 | 0 | 0 | 0 |
Lymphocytosis | 7 (7.8%) | 2 | 0 | 2 | 1 | 2 |
Anemia | 29 (32.2%) | 11 | 3 | 4 | 3 | 8 |
Thrombocytopenia | 5 (5.6%) | 1 | 1 | 2 | 1 | 0 |
Positive CRP | 79 (88.9%) | 24 | 9 | 15 | 7 | 25 |
Radiological findings | ||||||
Patchy consolidation | 73 (81.1%) | 21 | 9 | 13 | 5 | 25 |
Lobar consolidation | 14 (15.6%) | 4 | 0 | 4 | 2 | 4 |
Interstitial consolidation | 3 (3.3%) | 1 | 0 | 0 | 0 | 2 |
*p value < 0.05
R.R.: respiratory rate; CRP: C-reactive protein.
Data are presented as mean ± standard deviation or median for continuous variables and as number (percentage) for categorical variables
An etiologic agent was identified in 59 patients (65.5%). Bacterial pathogens were detected in 43 (47.8%) of the cases while viral pathogens were detected in 23 (25.5%). Coinfection with more than one etiologic agent was found in seven patients (7.8%). The most common typical bacterial cause of pneumonia was Staphylococcus aureus (n = 12; 13.3%) followed by S. pneumoniae (n = 7; 7.8%) and Klebsiella pneumoniae (n = 7; 7.8%). The commonest atypical bacterium was M. pneumoniae (n = 10; 11.1%), whereas the commonest viral etiologies were influenza A and B viruses (n = 11; 12.2%) (Table 2).
Table 2.
Patients | Number | % |
---|---|---|
Unidentified | 31 | 34.4 |
Identified | 59 | 65.5 |
Bacterial | 43 | 47.8 |
Staphylococcus aureus | 12 | 13.3 |
Streptococcus pneumoniae | 7 | 7.8 |
Klebsiella pneumoniae | 7 | 7.8 |
Haemophilus influenzae | 2 | 2.2 |
Escherichia coli | 2 | 2.2 |
Pseudomonas aeruginosa | 1 | 1.1 |
Atypical bacteria | 12 | 13.3 |
Mycoplasma pneumoniae | 10 | 11.1 |
Chlamydophila pneumoniae | 1 | 1.1 |
Legionella pneumophila | 1 | 1.1 |
Viral | 23 | 25.5 |
Influenza A virus | 7 | 7.8 |
Influenza B virus | 4 | 4.4 |
Para influenza virus 1–3 | 5 | 5.5 |
RSV | 4 | 4.4 |
Adeno virus | 3 | 3.3 |
Mixed | 7 | 7.8 |
Bacterial – bacterial | 2 | 2.2 |
Escherichia coli and Mycoplasma pneumoniae | 1 | 1.1 |
Pseudomonas aeruginosa and Mycoplasma pneumoniae | 1 | 1.1 |
Bacterial – viral | 4 | 4.4 |
Escherichia coli and RSV | 1 | 1.1 |
Staphylococcus aureus and influenza A virus | 1 | 1.1 |
Klebsiella pneumoniae and adeno virus | 1 | 1.1 |
Mycoplasma pneumoniae and adeno A virus | 1 | 1.1 |
Viral – viral | 1 | 1.1 |
Influenza A and parainfluenza virus | 1 | 1.1 |
RSV: Respiratory Syncytial Virus
The most common presenting symptoms were rhinitis (n = 86; 95.6%) and fever (92.2%). With respect to examination, fast breathing was found in 100% of patients and 22 (24.4%) with cyanosis. The commonest auscultatory findings were fine crepitation (n = 89; 99%) and diminished breath intensity (n = 84; 93.3%).
Comparing the demographic characteristics of patients in different etiological categories (typical bacterial, atypical bacterial, viral, mixed, and unidentified) revealed no significant differences among etiological categories except for rural residence which was significantly higher in patients with unidentified etiology (p < 0.05). As for the clinical findings, grunting was also significantly higher in patients with unidentified etiology and a significantly high respiratory rate was observed among patients with nonviral etiology. Severe respiratory distress was significantly higher in patients who had at least one pathogen detected than those with no identified etiology as well as in those with mixed etiologies (more than one pathogen detected) compared to the rest of the patients (p < 0.05).
The recorded routine laboratory results showed that CRP was positive in 80 (88.9%) patients. The commonest blood picture abnormality was leukocytosis (45.6%) followed by anemia (32.2%) and neutrophilia (28.9%) which was significantly evident in children with nonviral CAP (p < 0.05) (Table 2).
According to chest radiography, patchy consolidation was the predominant finding (81.1%), followed by lobar (15.6%) and interstitial (3.3%) patterns of consolidation. There was no correlation between radiological findings and etiologies (Table 2).
As for the diagnostic techniques employed in the study, culture of respiratory specimens was positive in 31.1% of cases, whereas Pneumoslide immunofluorescent IgM test yielded 36.7% positive result. Blood culture was done for 89 patients and was found positive in only 3.33% (Table 3).
Table 3.
Diagnostic technique | Number | % |
---|---|---|
Culture of respiratory specimens | ||
Negative | 62 | 68.9 |
Positive | 28 | 31.1 |
Staphylococcus aureus | 10 | 11.1 |
Streptococcus pneumoniae | 7 | 7.8 |
Klebsiella pneumoniae | 6 | 6.7 |
Haemophilus influenzae | 2 | 2.2 |
Escherichia coli | 2 | 2.2 |
Pseudomonas aeruginosa | 1 | 1.1 |
Blood culture | ||
Negative | 85 | 94.4 |
Positive | 3 | 3.3 |
Staphylococcus aureus | 2 | 2.2 |
Klebsiella pneumoniae | 1 | 1.1 |
Contamination | 1 | 1.1 |
Not done | 1 | 1.1 |
Pneumoslide-M test | ||
Negative | 57 | 63.3 |
Positive | 33 | 36.7 |
Mycoplasma pneumoniae | 9 | 10.0 |
Chlamydophila pneumoniae | 1 | 1.1 |
Legionella pneumophila | 1 | 1.1 |
Mycoplasma pneumoniae and influenza A virus | 1 | 1.1 |
Influenza A virus | 5 | 5.6 |
Influenza B virus | 4 | 4.4 |
Para influenza virus 1–3 | 4 | 4.4 |
Respiratory syncytial virus | 4 | 4.4 |
Adeno virus | 3 | 3.3 |
Influenza A virus and parainfluenza virus | 1 | 1.1 |
Discussion
The present study included 90 immunocompetent infants and preschool children hospitalized for CAP in a trial to identify the causative microbial etiology. The use of conventional methods of bacterial isolation parallel to the serological detection of specific IgM antibodies against common respiratory pathogens led to identifying at least one organism in 65.5% of the patients. In similar worldwide studies, the rate of pathogen detection varied widely ranging from as low as 38.4% [14] and 48% [15] to >80% [16–18]. The high rates of detection in the later studies could not be achieved in our study, considering their employment of invasive methods of specimen collection in some cases and the wide armamentarium of microbiologic diagnostic methods including viral isolation, antigen detection, and molecular techniques. Besides that, the negative history of antimicrobial intake before presentation could not be guaranteed, considering the fact that antimicrobials are readily purchased in Egypt without prescription.
Bacterial and viral pathogens were detected in 47.8% and 25.5% of the cases, respectively. These figures came very close to those reported previously [16, 19, 20]. Most of the identified bacteria were isolated by culture of respiratory specimens. Blood cultures yield was very limited (3.3%). Contamination was found in 1.1%. These results were consistent with those of other investigators who found rates of positive blood cultures range from 1 to 8% [15, 21]. Thus, the real benefit of routine blood culture in pediatric CAP remains in question because of the contrasting published conclusions. Most investigators suggest that blood cultures are likely to be unhelpful for management and can be omitted especially in mild and moderate CAP for cost–benefit reasons, while others still find that positive blood cultures can guide antibiotic therapy to narrow-spectrum [21–23]. The findings in this study were also conflicting, as, though the yield of blood culture was relatively low, the three isolated pathogens were not identified by respiratory specimen cultures. Therefore, the role of blood culture in redirecting the antimicrobial therapy still needs to be elucidated.
Pneumoslide-M was used in the study as it has been previously evaluated as a rapid feasible multiple panel test for detection of several viruses and atypical bacteria with sensitivity comparable to polymerase chain reaction (PCR) [13, 24, 25]. In the light of fact that each community has its specific pathogens as a leading cause of CAP, the use of pneumoslide-M was a tool for expanding the panel of pathogen identification and we did not aim to evaluate the sensitivity of the test; however, results of this study revealed a lower rate of positive results using pneumoslide-M (33/90; 36.7%) when compared with other studies (31/60; 51.66%) [13] and (624/1204; 51.83%) [25].
In this study, S. aureus was found the most common typical respiratory pathogen causing CAP (13.3%) in contrast to other published reports in which it used to come after S. pneumoniae and Haemophilus influenzae in frequency [14, 17, 26]. However, our finding is supported by that of Atwa [27], who detected S. aureus as the most common isolated organism from sputum of children with CAP in Egypt. These findings highlight the potentially rising role of this pathogen in our community where methicillin resistance has been extensively reported lately [28–30]. The role of S. aureus in CAP has also been the focus of other studies [31, 32]. It was reported after influenza epidemics [33] and was found the most common bacterial coinfection among adults during influenza pandemic in 2009 with the majority being methicillin-resistant S. aureus and associated with unfavorable prognosis [34]. In the current study, only one patient had evidence of coinfection with S. aureus and influenza virus.
Pneumonia caused by atypical bacteria solely counted for 10% of the cases. It has well been established that M. pneumoniae has always played a more crucial role in CAP among older age groups [35]. Evidence of M. pneumoniae infection in this study was detected in ten patients (11.1%); in three of them, it was found mixed with either bacterial or viral infection. Similar rates were recorded by Layani-Milon et al. and Chiang et al. [14, 36]. This finding drives the attention to the role of CAP caused by M. pneumoniae in children less than 5 years old even if the rates had not reached those recorded among older age groups [37].
The most common viral infection causing CAP was influenza viruses (12.2%). Earlier studies had named influenza virus as the best example of primary viral pneumonia [38]. Comparable rates were documented in the same age group by more recent studies [39, 40]. RSV was less reported in our study (4.4%) compared to other studies as we excluded children with bronchiolitis. Evidence of viral and bacterial coinfection was detected in four cases. However, the lack of viral isolation or antigen detection assays in the study halted the determination of the exact pathogenesis whether these were concomitant or secondary bacterial infections.
Interestingly, Pseudomonas aeruginosa, an uncommon cause of CAP [41], was isolated from a patient who had serological evidence of M. pneumoniae infection. It should be mentioned that the patient presented in bad general condition that necessitated admission to the intensive care unit and mechanical ventilation.
Supporting previous reports, we found that clinical manifestations, and laboratory and radiographic findings are poor indicators of the underlying etiology in childhood pneumonia [35]. Except for the severe respiratory distress that was significantly higher in patients with identified causative agent and also in patients with mixed infections when compared to other groups, all other clinical manifestations did not show association of significant importance in this study. Even the historical clinical differentiation between typical bacterial pneumonia and atypical pneumonia had been shown as an inaccurate reflection for the etiology [42]. Coinciding with Elemraid et al. [43], we found neutrophilia more significant in patients with nonviral etiology.
Limitation
There are some limitations in this study that should be noted, including the relatively small-sized sample that was restricted to hospital admitted patients. Wider scale studies that include ambulatory patients are needed to provide more information about the etiological agents implicated in the disease. Microbiological techniques used in the study were limited to conventional bacteriological identification methods and serological assay against most common respiratory pathogens. Yet, more diagnostic modalities as PCR and viral antigen detection could aid in identifying more etiologic agents.
Conclusion
S. aureus, M. pneumoniae, and influenza viruses were the most detected causative agents identified in the study. Local therapeutic and prevention guidelines for CAP should have special focus on these agents. Clinical manifestations and radiologic findings could not be relied upon to differentiate between bacterial and viral pneumonia, which necessitate the adoption of rapid feasible microbiologic diagnostic technique to aid in the diagnosis and management of hospitalized patients.
Acknowledgements
The authors are grateful for the patients without whom this study would not have been done.
Funding Statement
Funding sources The authors have no funding to report.
References
- 1.Zar HJ, Ferkol TW: The global burden of respiratory disease – impact on child health. Pediatr Pulmonol 49(5), 430–434 (2014) [DOI] [PubMed] [Google Scholar]
- 2.Izadnegahdar R, Cohen AL, Klugman KP, Qazi SA: Childhood pneumonia in developing countries. Lancet Respir Med 1(7), 574–584 (2013) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.World Health Organization: World Health Statistics 2014 [Google Scholar]
- 4.Cardinale F, Cappiello AR, Mastrototaro MF, Pignatelli M, Esposito S: Community-acquired pneumonia in children. Early Hum Dev 89 (Suppl 3), S49–52 (2013) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Harris M, Clark J, Coote N, et al. : British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 66 (Suppl 2), ii1–23 (2011) [DOI] [PubMed] [Google Scholar]
- 6.Jones RN, Jacobs MR, Sader HS: Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Int J Antimicrob Agents 36(3), 197–204 (2010) [DOI] [PubMed] [Google Scholar]
- 7.World Health Organization: Pocketbook of Hospital Care for Children [Google Scholar]
- 8.Cherian T Mulholland EK Carlin JB et al.: Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 83(5), 353–359 (2005) [PMC free article] [PubMed] [Google Scholar]
- 9.Zar HJ, Tannenbaum E, Apolles P, Roux P, Hanslo D, Hussey G: Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child 82(4), 305–308 (2000) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Equi AC, Pike SE, Davies J, Bush A: Use of cough swabs in a cystic fibrosis clinic. Arch Dis Child 85(5), 438–439 (2001) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Murray PR, Washington JA: Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc 50(6), 339–344 (1975) [PubMed] [Google Scholar]
- 12.Collee J: Mackie & McCartney Practical Medical Microbiology. Churchill Livingstone, New York [Google Scholar]
- 13.El-Sahrigy SAF, Abdel-Rahman AMO, Shady EAEA, Attia HR, Gomaa HE: Pneumoslide-M technique for rapid detection of atypical pathogens in critically ill children with lower respiratory tract infections. J Med Sci 6(5), 793–799 (2006) [Google Scholar]
- 14.Chiang WC, Teoh OH, Chong CY, Goh A, Tang JPL, Chay OM: Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology 12(2), 254–261 (2007) [DOI] [PubMed] [Google Scholar]
- 15.Claesson BA Trollfors B Brolin I et al.: Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J 8(12), 856–862 (1989) [DOI] [PubMed] [Google Scholar]
- 16.Juvén T Mertsola J Waris M et al.: Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 19(4), 293–298 (2000) [DOI] [PubMed] [Google Scholar]
- 17.Honkinen M, Lahti E, Österback R, Ruuskanen O, Waris M: Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect 18(3), 300–307 (2012) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jain S, Self WH, Wunderink RG, et al. : Communityacquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med, 150714140110004 (2015) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Heiskanen-Kosma T Korppi M Jokinen C et al.: Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 17(11), 986–991 (1998) [DOI] [PubMed] [Google Scholar]
- 20.Don M, Fasoli L, Paldanius M, et al. : Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis 37(11–12), 806–812 (2005) [DOI] [PubMed] [Google Scholar]
- 21.Myers AL Hall M Williams DJ et al.: Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J 32(7), 736–740 (2013) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yen M Hu B Chen Y et al.: A prospective etiologic study of community-acquired pneumonia in Taiwan. Methods 104(10), 724–730 (2005) [PubMed] [Google Scholar]
- 23.Heine D, Cochran C, Moore M, Titus MO, Andrews AL: The prevalence of bacteremia in pediatric patients with community-acquired pneumonia: guidelines to reduce the frequency of obtaining blood cultures. Hosp Pediatr 3(2), 92–96 (2013) [DOI] [PubMed] [Google Scholar]
- 24.Rashed HG, H H, ElShanawey O, Hassan L: Adult community acquired pneumonia in Assiut University Hospital. Assiut Med J 30(1) (2006) [Google Scholar]
- 25.Chen K, Jia R, Li L, Yang C, Shi Y: The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patterns associated with age and season. BMC Public Health 15(1), 1–6 (2015) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Gentile A, Bardach A, Ciapponi A, et al. : Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Infect Dis 16(1), e5–15 (2012) [DOI] [PubMed] [Google Scholar]
- 27.Atwa ZTH: Usefulness of gender and abnormal blood count for predicting pneumonia outcome in children. Egypt J Chest Dis Tuberc 64(1), 169–174 (2014) [Google Scholar]
- 28.Ezzat ESM, Fahmy K, Amer A, Abdel-aziz R: Hospital and community acquired methicillin resistant Staphylococcus aureus infections and their association with Panton–Valentine leukocidin gene 16(3), 481–489 (2007) [Google Scholar]
- 29.Abdulghany HM, Khairy RM: The frequency of methicillin-resistant Staphylococcus aureus and coagulase gene polymorphism in Egypt. 2014 (2014) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Enany S, Yaoita E, Yoshida Y, Enany M, Yamamoto T: Molecular characterization of Panton–Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus isolates in Egypt. Microbiol Res 165(2), 152–162 (2010) [DOI] [PubMed] [Google Scholar]
- 31.Kallen AJ Brunkard J Moore Z et al.: Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 53(3), 358–365 (2009) [DOI] [PubMed] [Google Scholar]
- 32.Carrillo-Marquez MA, Hulten KG, Hammerman W, Lamberth L, Mason EO, Kaplan SL: Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children’s Hospital. Pediatr Infect Dis J 30(7), 545–550 (2011) [DOI] [PubMed] [Google Scholar]
- 33.Hageman JC Uyeki TM Francis JS et al.: Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12(6), 894–899 (2006) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Rice TW Rubinson L Uyeki TM et al.: Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 40(5), 1487–1498 (2012) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tsolia MN, Psarras S, Bossios A, et al. : Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 39 (April 2003), 681–686 (2004) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Layani-Milon MP Gras I Valette M et al.: Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods. J Clin Microbiol 37(6), 1721–1726 (1999) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Medjo B, Atanaskovic-Markovic M, Radic S, Nikolic D, Lukac M, Djukic S: Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Ital J Pediatr 40(1), 104 (2014) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yeldandi AV, Colby TV: Pathologic features of lung biopsy specimens from influenza pneumonia cases. Hum Pathol 25(1), 47–53 (1994) [DOI] [PubMed] [Google Scholar]
- 39.Samransamruajkit R Hiranrat T Chieochansin T et al.: Prevalence, clinical presentations and complications among hospitalized children with influenza pneumonia. Jpn J Infect Dis 61(6), 446–449 (2008) [PubMed] [Google Scholar]
- 40.Cevey-Macherel M Galetto-Lacour A Gervaix A et al.: Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 168(12), 1429–1436 (2009) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hatchette TF, Gupta R, Marrie TJ: Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis 31(6), 1349–1356 (2000) [DOI] [PubMed] [Google Scholar]
- 42.Michelow IC Olsen K Lozano J et al.: Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113(4), 701–707 (2004) [DOI] [PubMed] [Google Scholar]
- 43.Elemraid MA, Rushton SP, Thomas MF, Spencer DA, Gennery AR, Clark JE: Utility of inflammatory markers in predicting the aetiology of pneumonia in children. Diagn Microbiol Infect Dis 79(4), 458–462 (2014) [DOI] [PubMed] [Google Scholar]